No Data
No Data
Microsoft, Google and Meta bet on synthetic data to build AI models
Every clever response from chatbots is supported by massive amounts of data — in some cases trillions of words need to be extracted from articles, books, and online reviews to teach artificial intelligence systems to understand users' queries. The industry's traditional view is that creating the next generation of artificial intelligence products will require more and more information. However, there is a big problem with this plan: the quality data that can be provided on the internet is limited. To get this data, the common practice of artificial intelligence companies is to either pay publishers millions of dollars to license content or download data from websites and expose themselves
Massive data (603138.SH): net loss of 81.1827 million yuan in 2023
Gelonghui, April 18 | Massive Data (603138.SH) released its 2023 annual report. During the reporting period, it achieved operating income of 262 million yuan, a year-on-year decrease of 13.57%; net profit attributable to shareholders of listed companies - 81.1827 million yuan; and basic earnings per share - 0.29 yuan.
Massive Data (603138.SH): The database product was not used in iFLYTEK's Spark model
Gelonghui, March 19 | Massive Data (603138.SH) said on the investor interactive platform that the company's database products were not used in iFLYTEK's Spark model.
Guojin Securities: Innovative drugs are an important field for the implementation of scientific and technological progress. Overall, performance will rise simultaneously with market performance
Guojin Securities released a research report saying that global innovative drugs are an important field for realizing scientific and technological progress, and China's innovative drug industry chain is on the rise. With the full restoration of in-hospital diagnosis and treatment, the introduction of national incentives and support policies for innovative drugs one after another, and the pace of internationalization of Chinese pharmaceutical companies, the industry as a whole will usher in simultaneous improvements in performance and market performance. It is recommended to invest in two types of targets: 1) choose a racetrack, preferring domestic targets mapped by metabolic, neurological, and self-immune indications and cutting-edge innovators in overseas breakthroughs; 2) select leaders, which are optimistic about bottom-up and internationalization breakthroughs. Recommended attention: Cinda Biotech (01801), Kangfang Biology
South Korea plans to invest 121.9 billion won this year to support the cloud computing industry
South Korea's Ministry of Science and ICT said on Monday that it plans to invest 121.9 billion won (about 91.5 million US dollars) this year to support South Korea's cloud computing industry, an increase of 17.2 billion won over last year. South Korea's Ministry of Science and Technology said that cloud technology plays a key role in advancing artificial intelligence (AI) because it provides high-performance computing capabilities and massive data storage capabilities. In terms of details, Korea plans to invest 24 billion won in the development and commercialization of innovative cloud services, 7 billion won in cloud-based software as a service (SaaS), and 80 billion won in the transformation of software to SaaS this year
Massive data (603138.SH): 2023 pre-loss of about 85.5 million yuan
Gelonghui, January 24 | Massive Data (603138.SH) announced the 2023 annual performance pre-loss announcement. According to preliminary estimates by the financial department, the company expects to achieve net profit attributable to shareholders of listed companies in 2023 of around -85.5 million yuan. Compared with the same period last year (legally disclosed data), there will be a loss. The company expects to achieve net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss of about -96.1 million yuan in 2023.
No Data